Dr. Barón is Professor of Biostatistics and Informatics and has been a faculty member at the University of Colorado Denver since 1984. She is currently a Senior Biostatistician with the VA CART Program on cardiology outcomes research, Co-Investigator with the Denver-Seattle VA Center of Innovation, and MPI on a randomized clinical trial, joint with Vanderbilt University Medical Center, testing the clinical utility of biomarkers and CT imaging features in the management of intermediate risk pulmonary nodules. Her methodologic expertise is in the design and analysis of observational studies and her research focuses on cancer prevention and control, especially in lung cancer. She has a strong passion for teaching and mentoring, has developed and taught many introductory and advanced courses, and has mentored numerous MPH, MS and PhD students in biostatistics, PhD students in epidemiology, bioinformatics, and clinical sciences, and junior faculty in biostatistics and public health.
Areas of Expertise
- Prediction modeling for time to event and binary outcomes
- Biomarker discovery and validation
- Comparative effectiveness analysis using propensity score methods
Education, Licensure & Certifications
- University of Texas School of Public Health, PhD, Biometry, 1984
- University of Texas School of Public Health, MS, Biometry, 1980
- Rice University, BA, Mathematical Sciences, 1977
Resumes/CV:
Awards
- Faculty Member Inductee into the Alpha Upsilon Chapter (CSPH) of the Delta Omega Honorary Society in Public Health, Colorado School of Public Health, 2010.
- Visiting Scientist Fellowship Award, International Agency for Research on Cancer, Lyon France, 2006.
- Departmental Teaching Award - given by the Graduate Students in Public Health and Biometrics, University of Colorado, 1991, 1995, 2001.
- Ford Foundation Minority Postdoctoral Fellowship, 1986.
Courses
- BIOS 6611: Biostatistical Methods I
- BIOS 6629: Applied Survival and Longitudinal Data Analysis
- BIOS 6645: Predictive Analytics
- BIOS 6646: Survival Analysis
Research
- National Cancer Institute, Clinical Utility of Biomarker-Driven Management of Indeterminate Pulmonary Nodules. May 2021-April 2026. Role: MPI.
- Veterans Administration, Extension Funding: Cardiovascular Assessment, Reporting and Tracking System for Cath Labs (CART-CL) Project. December 2020-September 2021. Role: Co-I.
- National Cancer Institute, SPORE in Lung Cancer – Project 4 Biomarkers for early detection of lung cancer. May 2014-April 2019. Role: Project Co-PI.
- National Cancer Institute, SPORE in Lung Cancer – Biostatistics, Informatics and Bioinformatics Core. May 2014-April 2019. Role: Core Co-Director.
Publications and Presentations
- Maron BA, Brittan EL, Hess E, Waldo SW, Barón AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galiè N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020 Sep;8(9):873-884.
- Barón AE, Kako S, Feser WJ, Malinowski H, Merrick D, Garg K, Malkoski S, Pretzel S, Siegfried JM, Franklin WA, Miller Y, Wolf HJ, Varella-Garcia M. Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer. J Thorac Oncol 2017; 12(10):1512-1523.
- Barón AE, Asdigian NL, Gonzalez V, Aalborg J, Terzian T, Stiegmann RA, Torchia EC, Berwick M, Dellavalle RP, Morelli JG, Mokrohisky ST, Crane LA, Box NF. Interactions Between Ultraviolet Light and MC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes. Cancer Epidemiol Biomarkers Prev 2014; 23(12):2829-2839.
- Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310(17):1829-36.
- Marshall G, Barón AE. Linear discriminant models for longitudinal data. Stat Med 2000; 19(15):1969-1981.